Lesley Ann Sutton

Extensive intraclonal diversification in a subgroup of chronic lymphocytic leukemia patients with stereotyped IGHV4-34 receptors: implications for ongoing interactions with antigen.

IGHV3-21 gene frequency in a Swedish cohort of patients with newly diagnosed chronic lymphocytic leukemia.

Next generation RNA-sequencing in prognostic subsets of chronic lymphocytic leukemia.

Temporal dynamics of clonal evolution in chronic lymphocytic leukemia with stereotyped IGHV4-34/IGKV2-30 antigen receptors: longitudinal immunogenetic evidence.

Antigen selection in B-cell lymphomas--tracing the evidence.

A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma.

In situ Protein Detection for Companion Diagnostics.

IgG-switched CLL has a distinct immunogenetic signature from the common MD variant: ontogenetic implications.

Lymphoma development in patients with autoimmune and inflammatory disorders--what are the driving forces?

Immunogenetic studies of chronic lymphocytic leukemia: revelations and speculations about ontogeny and clinical evolution.

Clonal evolution in chronic lymphocytic leukemia: impact of subclonality on disease progression.

Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting.

An entity evolving into a community: defining the common ancestor and evolutionary trajectory of chronic lymphocytic leukemia stereotyped subset #4.

Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution.

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations.

Molecular evidence for antigen drive in the natural history of mantle cell lymphoma.

The complex interplay between cell-intrinsic and cell-extrinsic factors driving the evolution of chronic lymphocytic leukemia.

Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia.

ARResT/AssignSubsets: a novel application for robust subclassification of chronic lymphocytic leukemia based on B cell receptor IG stereotypy.

Prognostic relevance of MYD88 mutations in CLL: the jury is still out.

Antigen Selection Shapes the T-cell Repertoire in Chronic Lymphocytic Leukemia.

UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?

An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors.

Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.

Innovation in the prognostication of chronic lymphocytic leukemia: how far beyond TP53 gene analysis can we go?

Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study.

Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference.

Not all subclones matter in CLL.

The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia.

Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors.

ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres.

Massive and parallel expression profiling using microarrayed single-cell sequencing.

Numerous Ontogenetic Roads to Mantle Cell Lymphoma: Immunogenetic and Immunohistochemical Evidence.

Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes.

Immunoglobulin genes in chronic lymphocytic leukemia: key to understanding the disease and improving risk stratification.

No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy.

Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations.

Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia.

Automated shape-based clustering of 3D immunoglobulin protein structures in chronic lymphocytic leukemia.